Myelodysplastic Syndrome (MDS)
Showing NaN - NaN of 9
Myelodysplastic Syndrome (MDS) Trial in Cleveland (CPX-351)
Recruiting
- Myelodysplastic Syndrome (MDS)
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Apr 21, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020
Allogeneic HCT Compared to Chemotherapy in Older AML Patients
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Stanford, California
- +11 more
Nov 12, 2019
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Treosulfan)
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Birmingham, Alabama
- +22 more
Oct 10, 2016
Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)
Suspended
- Myelodysplastic Syndrome (MDS)
- Myelofibrosis (MF)
- KB004, Monoclonal Antibody
-
Palo Alto, California
- +8 more
Nov 13, 2015
Blood And Marrow Transplantation, Leukemia, Lymphoma Trial in United States (Fludarabine, Clofarabine, Busulfan, ATG, TBI
Unknown status
- Blood And Marrow Transplantation
- +6 more
- Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative)
- Fludarabine, Melphalan, ATG (Reduced Intensity)
-
La Jolla, California
- +3 more
Nov 14, 2013
Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)
Completed
- Myelodysplastic Syndrome (MDS)
- Ezatiostat Hydrochloride
-
Tucson, Arizona
- +35 more
Oct 10, 2011